A. M. Stoppa

2.5k total citations
34 papers, 1.5k citations indexed

About

A. M. Stoppa is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, A. M. Stoppa has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 12 papers in Immunology and 7 papers in Oncology. Recurrent topics in A. M. Stoppa's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (7 papers) and Immune Cell Function and Interaction (6 papers). A. M. Stoppa is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (7 papers) and Immune Cell Function and Interaction (6 papers). A. M. Stoppa collaborates with scholars based in France, United States and Canada. A. M. Stoppa's co-authors include Didier Blaise, D Maraninchi, Gérald Marit, Patrice Viens, Daniel Olive, Michel Attal, Catherine Payen, Norbert Vey, Nicole Dastugue and Pierre–Henri Bernard and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A. M. Stoppa

34 papers receiving 1.5k citations

Peers

Countries citing papers authored by A. M. Stoppa

Since Specialization

Citations

This map shows the geographic impact of A. M. Stoppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Stoppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Stoppa more than expected).

Fields of papers citing papers by A. M. Stoppa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Stoppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Stoppa. The network helps show where A. M. Stoppa may publish in the future.

Co-authorship network of co-authors of A. M. Stoppa

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Stoppa. A scholar is included among the top collaborators of A. M. Stoppa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Stoppa. A. M. Stoppa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PF598 STEM CELL YIELD AND TRANSPLANTATION IN TRANSPLANT‐ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING DARATUMUMAB + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D‐VTD): PHASE 3 CASSIOPEIA STUDY 2019 ·HemaSphere ·Cyrille Hulin, Philippe Moreau, Michel Attal, Karim Belhadj, Lotfi Benboubker, Denis Caillot, Thierry Façon, Laurent Garderet, (unknown), A. M. Stoppa, Brigitte Kolb, Mourad Tiab, Pieter Sonneveld, (unknown), Matthijs Westerman, Lixia Pei, Tobias Kampfenkel, Carla de Boer, Jessica Vermeulen, (unknown)	4
2	High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation 2007 ·Bone Marrow Transplantation ·Jean El Cheikh, C. Faucher, S. Fürst, (unknown), Pierre Berger, Norbert Vey, A. M. Stoppa, Réda Bouabdallah, J. A. Gastaut, Patrice Viens, Didier Blaise, Mohamad Mohty	47
3	Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group 2005 ·Leukemia ·Céline Callens, Sylvie Chevret, JM Cayuela, Bruno Cassinat, Emmanuel Raffoux, Stéphane de Botton, Xavier Thomas, A. Guerci, Nathalie Fegueux, Arnaud Pigneux, A. M. Stoppa, Thierry Lamy, Françoise Rigal‐Huguet, Anne Vekhoff, Sandrine Meyer‐Monard, Audrey Ferrand, Miguel Á. Sanz, Christine Chomienne, Pierre Fenaux, Hervé Dombret, (unknown)	91
4	Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen 2003 ·Leukemia ·Mohamad Mohty, William Jacot, Catherine Faucher, Jacques‐Olivier Bay, Christine Zandotti, (unknown), (unknown), Karin Bilger, Olivier Tournilhac, Norbert Vey, A. M. Stoppa, Diane Coso, J.A. Gastaut, Patrice Viens, D Maraninchi, Daniel Olive, Didier Blaise	80
5	Anästhesie zur Sectio caesarea 2003 ·Der Anaesthesist ·(unknown), P Meyer, A. M. Stoppa, (unknown), Péter Bayer, (unknown)	12
6	Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy 2001 ·European Journal of Nuclear Medicine and Molecular Imaging ·I. Brenot-Rossi, Réda Bouabdallah, (unknown), V J Bardou, A. M. Stoppa, Jacques Camerlo, R Sauvan, J.A. Gastaut, J. Pasquier	12
7	Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission. 2000 ·PubMed ·Didier Blaise, Michel Attal, Josy Reiffers, Mauricette Michallet, (unknown), J. L. Pico, A. M. Stoppa, Catherine Payen, Gérald Marit, Réda Bouabdallah, (unknown), Jean‐François Rossi, M. Brandely, Thierry Hercend, D Maraninchi	52
8	Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high–intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin’s lymphoma: an oligocentric report on 42 patients 1999 ·Leukemia ·Réda Bouabdallah, A. M. Stoppa, JF Rossi, G. Lepeu, Diane Coso, Luc Xerri, Patrick Ladaique, (unknown), Didier Blaise, (unknown), Claude Alzieu, J. A. Gastaut, D Maraninchi	9
9	Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet Recovery 1996 ·Journal of Hematotherapy ·Catherine Faucher, Anne‐Gaëlle Le Corroller, Christian Chabannon, Patrice Viens, A. M. Stoppa, Réda Bouabdallah, Jacques Camerlo, Norbert Vey, Gwénaëlle Gravis, J.A. Gastaut, D Maraninchi, Didier Blaise	43
10	High-dose therapy in multiple myeloma: A prospective randomized study of the “intergroupe français du myelome” 1996 ·Stem Cells ·Michel Attal, Jean‐Luc Harousseau, A. M. Stoppa, J. J. Sotto, (unknown), Jean‐François Rossi, Philippe Casassus, Antoine Thyss, Hervé Maisonneuve, Thierry Façon, Norbert Ifrah, Catherine Payen, Régis Bataille	16
11	Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. 1995 ·PubMed ·Nicole Dastugue, Catherine Payen, Mårina Lafage‐Pochitaloff, Pierre–Henri Bernard, (unknown), (unknown), A. M. Stoppa, Gérald Marit, Lysiane Molina, Marie‐Cécile Michallet	199
12	Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma 1995 ·Blood ·JL Harousseau, Michel Attal, Marine Diviné, Gérald Marit, V. Leblond, A. M. Stoppa, JH Bourhis, Denis Caillot, M Boasson, JF Abgrall	123
13	Autoimmune polyendocrine failure — Type 1 (insulin-dependent) diabetes mellitus and hypothyroidism — after allogenic bone marrow transplantation in a patient with lymphoblastic leukaemia 1993 ·Diabetologia ·B. Vialettes, D Maraninchi, (unknown), F Birg, A. M. Stoppa, (unknown), Charles Thivolet, (unknown), P Vague, P. Mercier	44
14	A tumour‐associated antigen expression in human haematological malignancies 1993 ·British Journal of Haematology ·Hérvè Chambost, F. Brasseur, Pierre G. Coulie, Etienne De Plaen, A. M. Stoppa, D Baume, P Mannoni, Thierry Boon, D Maraninchi, Daniel Olive	34
15	In vitro inhibition of interleukin‐2‐induced defective polymorphonuclear chemotaxis by TNF inhibitor 1993 ·European Journal Of Haematology ·C. Fossat, D Sainty, A. M. Stoppa, Didier Blaise, Matthias David, D Maraninchi, I. Juhan‐Vague	2
16	Therapy-related acute promyelocytic leukemia: a report on 16 cases. 1992 ·Journal of Clinical Oncology ·Laurence Detourmignies, Sylvie Castaigné, A. M. Stoppa, J L Harousseau, Alain Sadoun, Maud Janvier, JL Demory, Miguel Á. Sanz, Roland Berger, F Bauters	79
17	High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse 1991 ·Blood ·D Maraninchi, Didier Blaise, Patrice Viens, M. Brandely, Daniel Olive, Marc Lopez, Danielle Sainty, Gérald Marit, A. M. Stoppa, Josy Reiffers	78
18	Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia 1991 ·Blood ·(unknown), Marina Lafage, Pierre Lévy, Didier Blaise, A. M. Stoppa, Patrice Viens, P Mannoni, D Maraninchi	70
19	Fractionated total body irradiation and bone marrow transplantation in acute lymphoblastic leukemia 1990 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), M. Resbeut, Didier Blaise, D Maraninchi, A. M. Stoppa, Jean‐Léon Lagrange, Jean‐Gerard Guillet, Y Carcassonne	15
20	Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission. 1988 ·PubMed ·Gérard Michel, D Maraninchi, F Deméocq, H Perrimond, Didier Blaise, M Gaspard, A. M. Stoppa, J A Gastaut, G. Lepeu, G Novakovitch	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact